ArticleInflammopharmacology2021

Neuroprotective effects of roflumilast against quinolinic acid-induced rat model of Huntington's disease through inhibition of NF-κB mediated neuroinflammatory markers and activation of cAMP/CREB/BDNF signaling pathway.

Priyanka Saroj et al.PubMed ↗Publisher ↗

No numbers read from the abstract.